Keloid Clarity

Explainer · July 25, 2026 · 5 min · By Phineas Walcott

Why Cutting a Keloid Out Often Makes It Bigger, and What Actually Lowers the Odds

Surgical excision alone has some of the highest recurrence rates in scar medicine. Here is the biology behind that, and the combination protocols that change the math.

Why Cutting a Keloid Out Often Makes It Bigger, and What Actually Lowers the Odds

One of the most common questions people ask after a keloid diagnosis is the most intuitive one: can a surgeon just cut it off? The honest answer is yes, a surgeon can, and in many cases the keloid will come back, sometimes larger than the original. Published recurrence rates for excision alone typically fall in the range of 45 to 100 percent depending on the body site and the study. Understanding why requires a short detour into what a keloid actually is.

A keloid is not a lump sitting on normal skin. It is the visible result of a wound healing process that never received the signal to stop. In typical healing, fibroblasts, the cells that build collagen scaffolding, ramp up production after injury and then wind down over weeks to months. In keloid-prone skin, those fibroblasts stay switched on. They overrespond to growth signals, especially transforming growth factor beta, and they keep depositing thick, disorganized collagen well past the boundaries of the original wound. That last part is the defining feature: keloids grow beyond the injury, unlike hypertrophic scars, which stay within it.

Now consider what excision does. Surgery is, by definition, a fresh wound. In a person whose fibroblasts already demonstrated a tendency to overshoot, a new incision hands those same cells a new construction site, often a longer one than the original injury. The surgical wound also sits under tension, and mechanical tension is one of the best documented drivers of keloid formation. Skin that is stretched during healing produces more inflammatory signaling and more collagen. This is part of why keloids favor high-tension zones like the chest, shoulders, upper back, and jawline, and why an excision scar across those areas is at particular risk.

So why do surgeons still operate on keloids? Because excision remains genuinely useful when it is paired with something that interrupts the rebound. The modern standard is not surgery alone but surgery plus an adjuvant, meaning a second treatment aimed at the healing wound itself. Three approaches have the strongest track records.

Corticosteroid injection after excision. Triamcinolone injected into the healing wound edges suppresses fibroblast activity and inflammatory signaling. Protocols vary, but injections typically begin at or shortly after suture removal and repeat every few weeks for several months. Combined excision and steroid injection brings recurrence down substantially compared with surgery alone, though reported rates still vary widely, roughly 15 to 50 percent across studies. Steroids carry their own tradeoffs, including skin thinning, lightening of pigment, and visible small blood vessels at the injection site.

Postoperative radiation. A short course of superficial radiotherapy, usually delivered within 24 to 72 hours after excision, targets the proliferating fibroblasts before they can rebuild the keloid. This timing matters: fibroblasts are most radiosensitive when actively dividing, which happens early in wound healing. Multiple case series report recurrence rates below 20 percent with this combination, and it is often considered for large or repeatedly recurrent keloids. The main concerns are cost, access, and understandable patient hesitancy about radiation, though the doses used are low and delivered to a small skin field. Long term risk appears very small in the published literature, but it is a conversation worth having explicitly with a clinician.

Pressure therapy, especially for ears. Earlobe keloids after piercing are a special case with a favorable anatomy. After excision, custom or commercial pressure clip earrings worn for many hours a day over 6 to 18 months compress the healing tissue. Sustained pressure appears to reduce blood flow and mechanical stimulation in the wound, both of which quiet fibroblast activity. Excision plus diligent pressure therapy on earlobes achieves some of the best recurrence numbers in keloid care, with several series reporting rates under 10 percent. The catch is adherence: the earrings must be worn consistently for months, and stopping early is a common reason for failure.

What this means practically. If you are considering removal of a keloid, the most important question to ask is not whether the keloid can be excised but what the plan is for the weeks and months afterward. A proposal for excision with no adjuvant strategy, no injections, no radiation referral, no pressure protocol, deserves skepticism, because the biology strongly favors recurrence in that scenario. It is also worth asking about wound tension: techniques that close the wound with minimal stretch, and placement of incisions along relaxed skin lines, reduce one of the key triggers.

Keloids are frustrating precisely because they weaponize the body's normal repair system. Surgery alone asks that system to behave differently the second time without changing any of the conditions. Combination treatment changes the conditions. That distinction, more than any single technique, is what separates disappointing outcomes from durable ones.

Related reading: Can a tattoo cause a keloid? Risk, warning signs, and what to do.